Literature DB >> 28960576

Deregulation of selected microRNAs in sinonasal carcinoma: Value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma.

Helena Kovarikova1, Ivana Bubancova1, Jan Laco2, Katerina Sieglova2, Hana Vosmikova2, Milan Vosmik3, Pavel Dundr4, Kristyna Nemejcova4, Jaroslav Michalek5, Vladimir Palicka1, Marcela Chmelarova1.   

Abstract

BACKGROUND: Tumors occurring in the sinonasal area are characterized by unfavorable outcome due to difficult diagnosis, treatment, and prognosis of the disease corresponding with the anatomic complexity of the area.
METHODS: We used quantitative real-time polymerase chain reaction (PCR) to compare relative expression of miR-21, miR-141, and miR-200c in 70 formalin-fixed, paraffin-embedded samples of sinonasal carcinoma tissue (majority of squamous cell carcinoma [SCC] samples) with 17 control samples of sinonasal tissue.
RESULTS: Our data showed significant upregulation of miR-21 in sinonasal cancer tissue. Expression levels of miR-141 and miR-200c were below detectable levels in both sinonasal cancer samples and healthy tissue. Kaplan-Meier analysis with log-rank survival showed that patients with SCC with high expression of miR-21 (highest quartile) had impaired survival close to reaching statistical significance (P = .0630).
CONCLUSION: Our results suggest that miR-21 upregulation is involved in tumorigenesis of sinonasal carcinoma and that it is associated with poor prognosis. Thus, miR-21 could be used as a valuable prognostic biomarker.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; head and neck cancer; miR-21; microRNA; sinonasal carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28960576     DOI: 10.1002/hed.24930

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.

Authors:  Jan Laco; Helena Kovaříková; Marcela Chmelařová; Hana Vošmiková; Kateřina Sieglová; Ivana Baranová; Pavel Dundr; Kristýna Němejcová; Jaroslav Michálek; Jana Šatanková; Milan Vošmik; Aleš Ryška
Journal:  Virchows Arch       Date:  2018-01-11       Impact factor: 4.064

2.  MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation.

Authors:  Petr Celakovsky; Helena Kovarikova; Viktor Chrobok; Jan Mejzlik; Jan Laco; Hana Vosmikova; Marcela Chmelarova; Ales Ryska
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 3.  Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.

Authors:  Matt Lechner; Jacklyn Liu; Valerie J Lund
Journal:  Curr Oncol Rep       Date:  2020-07-29       Impact factor: 5.075

4.  A Novel LncRNA, AC091729.7 Promotes Sinonasal Squamous Cell Carcinomas Proliferation and Invasion Through Binding SRSF2.

Authors:  Boyu Yu; Linmei Qu; Tianyi Wu; Bingrui Yan; Xuan Kan; Xuehui Zhao; Like Yang; Yushan Li; Ming Liu; Linli Tian; Yanan Sun; Qiuying Li
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

Review 5.  Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.

Authors:  Mario Turri-Zanoni; Giacomo Gravante; Paolo Castelnuovo
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.